Mpex Pharmaceuticals

About:

Mpex Pharmaceuticals is focused on developing new therapies to fight the growing issue of antibiotic resistance.

Website: http://www.mpexpharma.com

Top Investors: Adams Street Partners, SV Health Investors, Investor Growth Capital Limited, Aberdare Ventures, HBM Healthcare Investments

Description:

Mpex Pharmaceuticals is a biopharmaceutical company developing new therapies to combat the growing issue of antibiotic resistance, with a particular focus on gram-negative organisms. The Company's internal development pipeline focuses on combining proprietary formulations, PK/PD strategies and novel potentiating agents with proven antibiotics to overcome or directly inhibit the molecular mechanisms in bacteria responsible for antibiotic resistance.

Total Funding Amount:

$59.5M

Headquarters Location:

San Diego, California, United States

Founded Date:

2001-01-01

Contact Email:

info(AT)mpexpharma.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2009-02-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai